Metabolism of xenobiotics in the central nervous system. Implications and challenges

Biochemical Pharmacology

Volumn 56, Issue 5, 1998, Pages 547-551

  Ravindranath, V ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Brain; Cytochrome P450; Drug metabolism; Monooxygenase; Neurodegeneration; Psychoactive drugs

Indexed keywords

CYTOCHROME P450; PSYCHOTROPIC AGENT; UNSPECIFIC MONOOXYGENASE; XENOBIOTIC AGENT;

BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031671444     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00671-0     Document Type: Article

References (46)

1. P. Ortiz de Montellano Cytochrome P-450—Structure, Mechanism and Biochemistry 1986 Raven Press New York
2. T.E. Gram L.R. Okine R.A. Gram The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity Annu Rev Pharmacol Toxicol 26 1986 259 291
3. T.L. McLemore C.L. Litterst B.P. Coudert M.C. Liu W.C. Hubbard S. Adelberg M. Czerwinski J.A. McMahon J.C. Eggleston M.R. Boyd Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines J Natl Cancer Inst 82 1990 1420 1426
4. R. Michels P.M. Marzuk Progress in psychiatry N Engl J Med 329 1993 552 560
5. F.J. Gonzalez Human cytochromes P-450 Problems and prospects Trends Pharmacol Sci 13 1992 346 353
6. K. Brosen Recent developments in hepatic drug oxidation Implications for clinical pharmacokinetics Clin Pharmacokinet 18 1990 220 239
7. K. Brosen T. Zeugin U.A. Meyer Role of P-450IID6, the target of the sparteine/debrisoquin oxidation polymorphism, in the metabolism of imipramine Clin Pharmacol Ther 49 1991 609 617
8. S.V. Otton T. Inaba W. Kalow Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs Life Sci 32 1983 795 800
9. W. Daniel M. Melzacka The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain Biochem Pharmacol 35 1986 3249 3253
10. L. Bertilsson T.K. Henthorn E. Sanz G. Tybring J. Sawe T. Villen Importance of genetic factors in the regulation of diazepam metabolism Relationship to S -mephenytoin, but not debrisoquine hydroxylation phenotype Clin Pharmacol Ther 45 1989 348 355
11. W. Kalow R.F. Tyndale Debrisoquine/sparteine monooxygenase and other P-450s in brain W. Kalow Pharmacogenetics of Drug Metabolism 1992 Pergamon Press New York 649 656
12. O. Mortimer K. Persson G. Ladona D. Spalding U.M. Zanger U.A. Meyer A. Rane Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan Relationship to the presence of immunoidentified cytochrome P-450IID1 Clin Pharmacol Ther 47 1990 27 35
13. S.H. Sindrup K. Brosen P. Bjerring L. Arendt-Nielsen H.R. Angelo L.F. Gram The effect of quinidine on the analgesic effect of codeine Eur J Clin Pharmacol 42 1992 587 591
14. Z.R. Chen R.J. Irvine F. Bodiner A.A. Somogy Morphine formation from codeine in rat brain A possible mechanism of codeine analgesia Life Sci 46 1990 1067 1074
15. S.H. Sindrup L. Arendt-Nielsen K. Brosen P. Bjerring U. Larsen H.R. Angelo L.F. Gram Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine Clin Pharmacol Ther 48 1992 686 693
16. K. Brosen S.H. Sindrup E. Skjelbo K.K. Nielsen L.F. Gram Role of genetic polymorphism in psychopharmacology—An update Psychopharmacol Ser 10 1993 199 211
17. H. Sasame M. Ames S.D. Nelson Cytochrome P-450 and NADPH cytochrome c reductase in rat brain Formation of catechols and reactive catechol metabolites Biochem Biophys Res Commun 78 1977 919 926
18. V. Ravindranath H.K. Anandatheerthavarada Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method Anal Biochem 187 1990 310 313
19. M. Iscan K. Reuhl B. Weiss M.D. Maines Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain The olfactory bulb and the mitochondrial fraction have high levels of activity Biochem Biophys Res Commun 169 1990 858 863
20. H.K. Anandatheerthavarada J.F. Williams L. Wecker The chronic administration of nicotine induces cytochrome P-450 in rat brain J Neurochem 60 1993 1941 1944
21. Tirumalai PS, Bhamre S, Sudarshan KC, Boyd MR and Ravindranath V, Expression of multiple forms of cytochrome P-450 and associated monooxygenase activities in rat brain regions. Biochem Pharmacol , in press.
22. V. Ravindranath H.K. Anandatheerthavarada S.K. Shankar NADPH cytochrome P-450 reductase in rat, mouse and human brain Biochem Pharmacol 39 1990 1013 1018
23. K.T. Shiverick M. Notelovitz Mestranol-induced hypertension Characterization of cytochrome P-450 dependent catechol estrogen formation in brain microsomes Biochem Pharmacol 32 1983 101 106
24. H.K. Anandatheerthavarada V. Ravindranath Administration of testosterone alleviates constitutive sex difference in rat brain cytochrome P-450 Neurosci Lett 125 1991 238 240
25. S. Bhamre H.K. Anandatheerthavarada S.K. Shankar V. Ravindranath Microsomal cytochrome P-450 in human brain regions Biochem Pharmacol 44 1992 1223 1225
26. V. Ravindranath H.K. Anandatheerthavarada S.K. Shankar Xenobiotic metabolism in human brain—Presence of cytochrome P-450 and associated monooxygenases Brain Res 496 1989 331 335
27. M. Das P.K. Seth H. Mukhtar Characterization of microsomal arylhydrocarbon hydroxylase of rat brain J Pharmacol Exp Ther 216 1981 156 161
28. H.K. Anandatheerthavarada S.K. Shankar S. Bhamre M.R. Boyd B.J. Song V. Ravindranath Induction of brain cytochrome P-450IIE1 by chronic ethanol treatment Brain Res 601 1993 279 285
29. J.A. Cohn A.P. Alvarez A. Kappas On the occurrence of cytochrome P-450 and aryl hydrocarbon hydroxylase activity in rat brain J Exp Med 145 1977 1607 1611
30. B. Walther J.F. Ghersi-Egea Z. Jayyosi A. Minn G. Siest Ethoxyresorufin O -deethylase activity in rat brain subcellular fractions Neurosci Lett 76 1987 58 62
31. A.V. Hodgson T.W. White J.W. White H.W. Strobel Expression analysis of the mixed function oxidase system in the rat brain by the polymerase chain reaction Mol Cell Biochem 120 1993 171 179
32. B. Schilter C.J. Omiecinski Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain Mol Pharmacol 44 1993 990 996
33. M. Komuri A novel P-450 expressed at the high level in rat brain Biochem Biophys Res Commun 196 1993 721 728
34. H.K. Anandatheerthavarada S.K. Shankar V. Ravindranath Rat brain cytochrome P-450 Catalytic, immunochemical properties and inducibility of multiple forms Brain Res 536 1990 339 343
35. R. Perrin A. Minn J.-F. Ghersi-Egea M.-C. Grassiot G. Seist Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and isolated cerebral microvessels Biochem Pharmacol 40 1990 2145 2151
36. T. Hansson N. Tindberg M. Ingelman-Sundberg C. Kohler Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system Neuroscience 34 1990 451 463
37. Z. Jayyosi K.O. Cooper P.E. Thomas Brain cytochrome P-450 and testosterone metabolism by rat brain subcellular fractions Presence of cytochrome P-4503A immunoreactive protein in rat brain mitochondria Arch Biochem Biophys 298 1992 265 270
38. R. Fonne-Pfister M.J. Bargetzi U.A. Meyer MPTP, the neurotoxin inducing Parkinson’s disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation Biochem Biophys Res Commun 148 1987 1144 1150
39. B.M.A. Näslund H. Glaumann M. Warner J-Å. Gustafsson T. Hansson Cytochrome P-450 b and c in the rat brain and pituitary gland Mol Pharmacol 33 1988 31 37
40. J.F. Ghersi-Egea B. Walther R. Perrin A. Minn G. Siest Inducibility of rat brain drug-metabolizing enzymes Eur J Drug Metab Pharmacokinet 12 1987 263 265
41. H. Kawashima D.J. Sequeira D.R. Nelson H.W. Strobel Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18 ∗ catalyzing imipramine N -demethylation J Biol Chem 271 1996 28176 28180
42. B. Volk U. Hettmannsperger T.H. Papp Z. Amelizad F. Oesch R. Knoth Mapping of phenytoin-inducible cytochrome P-450 immunoreactivity in the mouse central nervous system Neuroscience 42 1991 215 235
43. A. Dhawan D. Parmar M. Das P.K. Seth Cytochrome P-450 dependent monooxygenase in neuronal and glial cells Inducibility and specificity Biochem Biophys Res Commun 170 1990 441 447
44. K.F. Tipton T.P. Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1993 1191 1206
45. S.V. Bhagwat B.C. Leelavathi S.K. Shankar M.R. Boyd V. Ravindranath Cytochrome P-450 and associated monooxygenase activities in the rat and human spinal cord Induction, immunological characterization and immunocytochemical localization Neuroscience 68 1995 593 601
46. V. Ravindranath M.R. Boyd Xenobiotic metabolism in brain Drug Metab Rev 27 1995 419 448